Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First update of the living European guideline (EuroGuiDerm) on atopic eczema.
Wollenberg A, Kinberger M, Arents B, Aszodi N, Barbarot S, Bieber T, Brough HA, Pinton PC, Christen-Zaech S, Deleuran M, Dittmann M, Fosse N, Gáspár K, Gerbens LAA, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Rehbinder EM, Ring J, Rossi M, Roxburgh C, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. Wollenberg A, et al. Among authors: rossi m. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1283-e1287. doi: 10.1111/jdv.19269. Epub 2023 Jul 17. J Eur Acad Dermatol Venereol. 2023. PMID: 37328919 Free article. No abstract available.
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.
Pezzolo E, Schena D, Gambardella A, Rossi M, Barei F, Calzavara Pinton P, Girolomoni G, Naldi L, Ferrucci SM. Pezzolo E, et al. Among authors: rossi m. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e11-e13. doi: 10.1111/jdv.19382. Epub 2023 Aug 1. J Eur Acad Dermatol Venereol. 2024. PMID: 37483150 No abstract available.
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.
Chiricozzi A, Balato A, Fabbrocini G, Di Nardo L, Babino G, Rossi M, Esposito M, Bertoldi AM, Girolomoni G, Gambardella A, Antonelli F, Patruno C, Fargnoli MC, Argenziano G, Peris K. Chiricozzi A, et al. Among authors: rossi m. J Am Acad Dermatol. 2023 Dec;89(6):1251-1253. doi: 10.1016/j.jaad.2023.05.001. Epub 2023 May 9. J Am Acad Dermatol. 2023. PMID: 37169293 No abstract available.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.
Pezzolo E, Rossi M, Caroppo F, Bianchelli T, Belloni Fortina A, Giacchetti A, Calzavara Pinton P, Naldi L. Pezzolo E, et al. Among authors: rossi m. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e757-e759. doi: 10.1111/jdv.18889. Epub 2023 Feb 6. J Eur Acad Dermatol Venereol. 2023. PMID: 36662631 No abstract available.
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy.
Ventura P, Brancaleoni V, Di Pierro E, Graziadei G, Macrì A, Carmine Guida C, Nicolli A, Rossi MT, Granata F, Fiorentino V, Fustinoni S, Sala R, Pinton PC, Trevisan A, Marchini S, Cuoghi C, Marcacci M, Corradini E, Sorge F, Aurizi C, Savino MG, Cappellini MD, Pietrangelo A. Ventura P, et al. Among authors: rossi mt. Eur J Dermatol. 2020 Oct 1;30(5):532-540. doi: 10.1684/ejd.2020.3880. Eur J Dermatol. 2020. PMID: 33021473 Free article.
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST.
Fabbrocini G, Stingeni L, Hansel K, Corazza M, Ferrucci SM, Fargnoli MC, Foti C, Patruno C, Peris K, Pigatto P, Romanelli M, Rossi M, Schena D, Monfrecola G, Calzavara-Pinton P. Fabbrocini G, et al. Among authors: rossi m. Ital J Dermatol Venerol. 2023 Apr;158(2):81-83. doi: 10.23736/S2784-8671.23.07545-X. Ital J Dermatol Venerol. 2023. PMID: 37153942 No abstract available.
Bath-PUVA still represents a valuable treatment option for the subsets of psoriatic patients who are not eligible to or rejecting systemic treatments and are not responsive to NB-UVB phototherapy.
Calzavara-Pinton P, Arisi M, Tonon F, Calzavara-Pinton I, Venturini M, Rossi M. Calzavara-Pinton P, et al. Among authors: rossi m. Photodermatol Photoimmunol Photomed. 2023 Jul;39(4):351-356. doi: 10.1111/phpp.12846. Epub 2022 Dec 7. Photodermatol Photoimmunol Photomed. 2023. PMID: 36398948
6,415 results